CN Stock MarketDetailed Quotes

002390 Guizhou Xinbang Pharmaceutical

Watchlist
  • 2.96
  • -0.04-1.33%
Market Closed Sep 13 15:00 CST
5.75BMarket Cap23.31P/E (TTM)

Guizhou Xinbang Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Guizhou Xinbang Pharmaceutical Q2 2024 Earnings Date

Currency：CNYAug 31, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
1.46B
--
-11.34%
Net Income
--
79.75M
--
-38.16%
Analyst Rating
Strong Buy

Sep 13, 2024

Guizhou Xinbang Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2021/FY6.472B / 6.662B--
--2019/FY6.655B / 6.476B--
DatePeriodRevenue/EstimateEarnings Call
--2021/FY6.472B / 6.662B--
--2019/FY6.655B / 6.476B--
--------
--------
--------

Unlock Free Earnings Estimates

Guizhou Xinbang Pharmaceutical Earnings Reports

  • Xinbang Pharmaceuticals: 2024 Semi-Annual Report Summary

    Aug 30 12:00 ET

  • Xinbang Pharmaceuticals: 2024 Semi-Annual Report

    Aug 30 12:00 ET

  • Guizhou Xinbang Pharmaceutical: 2024 First Quarter Report

    Apr 28 12:00 ET

  • Xinbang Pharmaceuticals: 2023 Annual Report

    Apr 15 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Sep 13, 2024

    Strong Buy

    • Strong Buy

      100.00%

    • Buy

      0.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg

    No Data